#oncology

- Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of ...

- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung ...

- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its new FLOW system for use with Laboratory ...

- On September 3, 2013, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. officially signed a strategic cooperation ...

- On September 3, 2013, Shanghai Fosun Pharmaceutical (Group) Co., Ltd purchased a 50% stake in Guangzhou Nanyang ...

- Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform- TSX Exchange ...

- In conjunction with the inauguration of the Gamma Knife® Center Indonesia, Siloam International Hospitals Lippo ...

-11 Inaugural winners receive US$3 million each for Groundbreaking Achievements in Life Science ...

-- Experts recommend comprehensive approach to combat global health issue -     A new Economist ...

-- http://www.sirtex.com informs doctors, patients and investors about the world's most widely used and widely studied ...

Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than ...

-     FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast ...

-EffRx to Regain Rights Outside of North America     EffRx Pharmaceuticals SA [http://www.effrx.com ...

-ExAblate(R) MRI-guided Focused Ultrasound is effective in reducing pain from bone metastases in patients who could not ...

- Takeda Global Research and Development (Asia) Pte Ltd (TGRD Asia), a wholly owned subsidiary of Takeda Pharmaceutical ...